| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e0643957a3bb49169ff4be9f0063c298 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5078
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5042
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-433 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-433 |
| filingDate |
2017-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff42c77de42dcff07dceb3e93fc9f369
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3080cb7129c3fc6c615b55d94d8a00e2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1add1c652e2c680a844fdc23f8ac0214
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8d489cb29b24a3adfd68d424177ef3a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad71869e755e00e3f9ea347590c69bc9 |
| publicationDate |
2017-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2017222488-A1 |
| titleOfInvention |
Sustained release formulation comprising tizanidine |
| abstract |
The present invention relates to a sustained release multiparticulate formulation comprising Tizanidine or a pharmaceutically acceptable salt thereof. The multiparticulate form is used for the treatment of painful muscle spasms due to problems with spasticity and musculoskeletal system in the form of oral dosage forms such as capsules, sachets, tablets. |
| priorityDate |
2016-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |